A Dormant T-cell Population with Autoimmune Potential Exhibits Low Self-reactivity and Infiltrates Islets in Type 1 Diabetes
Overview
Authors
Affiliations
The contribution of low-affinity T cells to autoimmunity in the context of polyclonal T-cell responses is understudied due to the limitations in their capture by tetrameric reagents and low level of activation in response to antigenic stimulation. As a result, low-affinity T cells are often disregarded as nonantigen-specific cells irrelevant to the immune response. Our study aimed to assess how the level of self-antigen reactivity shapes T-cell lineage and effector responses in the context of spontaneous tissue-specific autoimmunity observed in NOD mice. Using multicolor flow cytometry in combination with Nur77 reporter of TCR signaling, we identified a dormant population of T cells that infiltrated the pancreatic islets of prediabetic NOD mice, which exhibited reduced levels of self-tissue reactivity based on expression of CD5 and Nur77 . We showed that these CD5 T cells had a unique TCR repertoire and exhibited low activation and minimal effector function; however, induced rapid diabetes upon transfer. The CD4 CD5 T-cell population displayed transcriptional signature of central memory T cells, consistent with the ability to acquire effector function post-transfer. Transcriptional profile of CD5 T cells was similar to T cells expressing a low-affinity TCR, indicating TCR affinity to be an important factor in shaping CD5 T-cell phenotype and function at the tissue site. Overall, our study suggests that autoimmune tissue can maintain a reservoir of undifferentiated central memory-like autoreactive T cells with pathogenic effector potential that might be an important source for effector T cells during long-term chronic autoimmunity.
Aljobaily N, Allard D, Perkins B, Raugh A, Galland T, Jing Y Immunity. 2024; 57(11):2583-2596.e6.
PMID: 39396521 PMC: 11563894. DOI: 10.1016/j.immuni.2024.09.016.
Grebinoski S, Pieklo G, Zhang Q, Visperas A, Cui J, Goulet J J Immunol. 2024; 213(6):779-794.
PMID: 39109924 PMC: 11371503. DOI: 10.4049/jimmunol.2300216.
Yang K, Zhang Y, Ding J, Li Z, Zhang H, Zou F Front Endocrinol (Lausanne). 2024; 15:1377322.
PMID: 38800484 PMC: 11116783. DOI: 10.3389/fendo.2024.1377322.
Delayed graft rejection in autoimmune islet transplantation via biomaterial immunotherapy.
Coronel M, Linderman S, Martin K, Hunckler M, Medina J, Barber G Am J Transplant. 2023; 23(11):1709-1722.
PMID: 37543091 PMC: 10837311. DOI: 10.1016/j.ajt.2023.07.023.
MHC Class II Presentation in Autoimmunity.
Ishina I, Zakharova M, Kurbatskaia I, Mamedov A, Belogurov Jr A, Gabibov A Cells. 2023; 12(2).
PMID: 36672249 PMC: 9856717. DOI: 10.3390/cells12020314.